Jeil Pharm
Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms i… Read more
Jeil Pharm (002620) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.031x
Based on the latest financial reports, Jeil Pharm (002620) has a cash flow conversion efficiency ratio of 0.031x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩14.16 Billion) by net assets (₩460.63 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jeil Pharm - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Jeil Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jeil Pharm Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jeil Pharm ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Donegal Investment Group PLC
IR:DQ7A
|
-0.234x |
|
Foresta Group Holdings Ltd
AU:FGH
|
-0.582x |
|
Carriesoft Co. Ltd
KQ:317530
|
-0.050x |
|
Puriblood Medical Co., Ltd.
TWO:6847
|
-0.073x |
|
US Energy Corp
NASDAQ:USEG
|
-0.006x |
|
Senheng New Retail Bhd
KLSE:5305
|
0.043x |
|
The Market Ltd
AU:MKT
|
N/A |
|
Asefa Public Company Limited
BK:ASEFA
|
0.121x |
Annual Cash Flow Conversion Efficiency for Jeil Pharm (2011–2024)
The table below shows the annual cash flow conversion efficiency of Jeil Pharm from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩437.40 Billion | ₩4.54 Billion | 0.010x | +194.59% |
| 2023-12-31 | ₩402.19 Billion | ₩-4.42 Billion | -0.011x | +77.84% |
| 2022-12-31 | ₩419.79 Billion | ₩-20.80 Billion | -0.050x | -284.97% |
| 2021-12-31 | ₩500.31 Billion | ₩13.40 Billion | 0.027x | +156.50% |
| 2020-12-31 | ₩499.28 Billion | ₩-23.67 Billion | -0.047x | -190.82% |
| 2019-12-31 | ₩483.04 Billion | ₩25.22 Billion | 0.052x | +996.58% |
| 2018-12-31 | ₩589.58 Billion | ₩-3.43 Billion | -0.006x | -116.75% |
| 2017-12-31 | ₩170.44 Billion | ₩5.92 Billion | 0.035x | -22.85% |
| 2016-12-31 | ₩252.08 Billion | ₩11.36 Billion | 0.045x | +296.38% |
| 2015-12-31 | ₩241.39 Billion | ₩2.74 Billion | 0.011x | +169.58% |
| 2012-12-31 | ₩241.41 Billion | ₩-3.94 Billion | -0.016x | -116.00% |
| 2011-12-31 | ₩231.40 Billion | ₩23.63 Billion | 0.102x | -- |